-Wyeth becomes the first multinational company to launch an HMO baby growth formula in China
SUZHOU, China, Nov. 14, 2023 /PRNewswire/ — On November 13, 2023, Wyeth Nutrition announced the launch of its first illuma HMO infant growth formula with two human milk oligosaccharides (HMOs) in China. Designed for babies over 3 years old, this product is manufactured in the company’s GMP-level factory in Suzhou. Illuma is now the first international company to introduce an HMO infant formula in China. The two added HMOs were recently approved as food additives by the National Health Commission of China on October 7, 2023.
HMOs are the third most abundant ingredients in breast milk after fat and lactose, and the number one immunomodulatory bioactive nutrients.
The two HMOs in the new illuma have been shown in clinical trials to help regulate the intestinal microbiota, minimize the risk of bronchitis and respiratory infections, and reduce the need for antibiotics and fever reducers.[1] Additionally, 35 vital nutrients are added to the illuma HMO growth formula. These nutrients aid eye development, stimulate brain development, and address a host of other nutritional requirements for growing children, in addition to boosting immunity.[2]
Wyeth Nutrition’s long-term dedication and strong research base in this area allowed them to become the first foreign company to launch this innovative product in China. Over his 30-year research career, he has published more than 70 research articles on HMOs and has obtained more than 100 HMO-related patents. With the addition of six crucial HMOs, the company’s newest infant formula product, illuma LUXA, has the highest number of HMOs of any infant formula on the market today.
The launch of illuma HMO growth formula demonstrates Wyeth Nutrition’s commitment “in China, for China”, as well as showcasing the company’s overall strength. Wyeth Nutrition will use its global resources for cutting-edge technology to leverage its continuous learnings about the needs of Chinese mothers and babies to accelerate formula improvements in the future. Meanwhile, Wyeth Nutrition will enhance its local supply chain, research and development and production footprints to better serve the wide range of nutritional demands in the Chinese market.
Photo – https://mma.prnewswire.com/media/2276099…Photo – https://mma.prnewswire.com/media/2276100…
View original content: https://www.prnewswire.com/news-releases/wyeth-primera-empresa-multinacional-en-lanzar-una-formula-de-crecimiento-para-bebes-hmo-en-china-301988041.html
